1. Home
  2. ONCO vs DOMH Comparison

ONCO vs DOMH Comparison

Compare ONCO & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCO
  • DOMH
  • Stock Information
  • Founded
  • ONCO 2018
  • DOMH 1967
  • Country
  • ONCO United States
  • DOMH United States
  • Employees
  • ONCO N/A
  • DOMH N/A
  • Industry
  • ONCO Biotechnology: Pharmaceutical Preparations
  • DOMH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ONCO Health Care
  • DOMH Health Care
  • Exchange
  • ONCO Nasdaq
  • DOMH Nasdaq
  • Market Cap
  • ONCO 9.4M
  • DOMH 8.8M
  • IPO Year
  • ONCO 2022
  • DOMH N/A
  • Fundamental
  • Price
  • ONCO $0.60
  • DOMH $3.02
  • Analyst Decision
  • ONCO
  • DOMH
  • Analyst Count
  • ONCO 0
  • DOMH 0
  • Target Price
  • ONCO N/A
  • DOMH N/A
  • AVG Volume (30 Days)
  • ONCO 10.5M
  • DOMH 421.3K
  • Earning Date
  • ONCO 12-10-2024
  • DOMH 03-31-2025
  • Dividend Yield
  • ONCO N/A
  • DOMH N/A
  • EPS Growth
  • ONCO N/A
  • DOMH N/A
  • EPS
  • ONCO N/A
  • DOMH N/A
  • Revenue
  • ONCO $1,870,605.00
  • DOMH $12,589,000.00
  • Revenue This Year
  • ONCO N/A
  • DOMH N/A
  • Revenue Next Year
  • ONCO N/A
  • DOMH N/A
  • P/E Ratio
  • ONCO N/A
  • DOMH N/A
  • Revenue Growth
  • ONCO N/A
  • DOMH 1117.50
  • 52 Week Low
  • ONCO $0.32
  • DOMH $0.83
  • 52 Week High
  • ONCO $21.40
  • DOMH $4.35
  • Technical
  • Relative Strength Index (RSI)
  • ONCO 51.04
  • DOMH 65.22
  • Support Level
  • ONCO $0.51
  • DOMH $2.86
  • Resistance Level
  • ONCO $0.70
  • DOMH $4.35
  • Average True Range (ATR)
  • ONCO 0.09
  • DOMH 0.52
  • MACD
  • ONCO 0.03
  • DOMH 0.14
  • Stochastic Oscillator
  • ONCO 34.45
  • DOMH 53.19

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.

Share on Social Networks: